Reply: Benefits of stopping therapy in patients with cirrhotic hepatitis B, true effect, or residual confounding?

Yun Fan Liaw*, Wen Juei Jeng, Rong Nan Chien

*Corresponding author for this work

Research output: Contribution to journalJournal Letter peer-review

2 Scopus citations
Original languageEnglish
Pages (from-to)E97-E98
JournalHepatology
Volume79
Issue number3
DOIs
StatePublished - 01 03 2024

Keywords

  • Humans
  • Hepatitis B/drug therapy
  • Hepatitis B, Chronic/drug therapy
  • Liver Cirrhosis/drug therapy
  • Hepatitis B virus/genetics
  • Antiviral Agents/therapeutic use
  • DNA, Viral
  • Hepatitis B e Antigens
  • Hepatitis B Surface Antigens

Cite this